{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:37:36Z","timestamp":1789468656434,"version":"build-2803163510"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T00:00:00Z","timestamp":1638057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1000201"],"award-info":[{"award-number":["2016YFC1000201"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1002104"],"award-info":[{"award-number":["2018YFC1002104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81730038"],"award-info":[{"award-number":["81730038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["GNT1176437"],"award-info":[{"award-number":["GNT1176437"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>Does in vitro maturation (IVM) result in non-inferior cumulative live birth rates compared to those after standard in vitro fertilization (IVF) in infertile women with polycystic ovary syndrome (PCOS)?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>One cycle of IVM, without any stimulation, was inferior to one cycle of standard IVF in women with PCOS in terms of 6-month cumulative live birth rates, when choosing single vitrified-warmed blastocyst transfer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>IVM is an emerging alternative treatment for women with PCOS who need assisted reproductive technology. Since a minimal or even zero dose of gonadotropins are required in the IVM procedure, the occurrence of ovarian hyperstimulation syndrome (OHSS) is eliminated. Only one clinical trial comparing the pregnancy outcome between IVM with FSH priming and IVF has been reported. However, it is still unknown whether IVM treatment without any stimulation can offer a similar live birth outcome in women with PCOS as compared to that in women receiving the standard IVF procedure with ovarian stimulation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>This single-centre, open-label randomized controlled non-inferiority trial in an academic infertility centre in China was performed between March 2018 and July 2019.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>Women aged 20\u201338 years with PCOS and infertility scheduled for their first IVF attempt were eligible. In total, 351 women were randomly allocated to receive one cycle of unstimulated IVM (n = 175) or one cycle of standard IVF with a flexible GnRH antagonist protocol and hCG as ovulatory trigger (n = 176). A freeze-all and single blastocyst transfer strategy was used in both groups. The primary outcome was ongoing pregnancy (leading to live birth) within 6 months after randomization. A non-inferiority margin of 15% was considered.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>The IVM procedure without additional gonadotropin resulted in a lower ongoing pregnancy (leading to live birth) within 6 months after randomization compared to standard IVF treatment (22.3% vs. 50.6%; rate difference \u221228.3%; 95% confidence interval [CI]: \u221237.9% to \u221218.7%). Moderate-severe OHSS did not occur in the IVM group, while in the IVF group, ten women (5.7%) had moderate OHSS and one woman (0.6%) had severe OHSS. There was no statistically significant difference in the occurrence of obstetric and perinatal complications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>The trial was conducted using an IVM protocol without additional stimulation in a single centre, which may limit its generalizability. In addition, a GnRH agonist trigger rather than hCG for IVF stimulation in women with PCOS would be more consistent with current clinical practice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>Although IVM is considered to be a convenient, inexpensive and safe alternative to IVF for women with PCOS, our results indicated that one cycle of IVM without any stimulation was inferior to one cycle of standard IVF in terms of the cumulative live birth rate. The inferiority of IVM without ovarian stimulation could be mainly due to the limitations in the developmental potential of embryos. Further IVM development should be tested and validated in a freeze-only and blastocyst transfer setting. Further RCTs are needed to evaluate the effectiveness and safety of other IVM protocols or multiple cycles of IVM compared to IVF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>This study was supported by the National Key Research and Development Program of China (2016YFC1000201 and 2018YFC1002104) and the National Science Foundation of China (81730038). B.W.M. is supported by a NHMRC Investigator grant (GNT1176437). All other authors declare no competing interests.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>Clinicaltrials.gov NCT03463772.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION DATE<\/jats:title>\n                  <jats:p>29 January 2018.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>DATE OF FIRST PATIENT\u2019S ENROLMENT<\/jats:title>\n                  <jats:p>16 March 2018.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deab243","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T12:46:59Z","timestamp":1635857219000},"page":"242-253","source":"Crossref","is-referenced-by-count":59,"title":["<i>In vitro<\/i> maturation without gonadotropins versus <i>in vitro<\/i> fertilization with hyperstimulation in women with polycystic ovary syndrome: a non-inferiority randomized controlled trial"],"prefix":"10.1093","volume":"37","author":[{"given":"Xiaoying","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Centre for Reproductive Medicine, Peking University Third Hospital, Beijing, China"},{"name":"National Clinical Research Centre for Obstetrics and Gynecology, Beijing, China"},{"name":"Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education, Beijing, China"},{"name":"Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China"},{"name":"Research Units of Comprehensive Diagnosis and Treatment of Oocyte Maturation Arrest, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Centre for Reproductive Medicine, Peking University Third Hospital, Beijing, China"},{"name":"National Clinical Research Centre for Obstetrics and Gynecology, Beijing, China"},{"name":"Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education, Beijing, China"},{"name":"Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zeng","sequence":"additional","affiliation":[{"name":"Research Centre of Clinical Epidemiology, Peking University Third Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Centre for Reproductive Medicine, Peking University Third Hospital, Beijing, China"},{"name":"National Clinical Research Centre for Obstetrics and Gynecology, Beijing, China"},{"name":"Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education, Beijing, China"},{"name":"Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Centre for Reproductive Medicine, Peking University Third Hospital, Beijing, China"},{"name":"National Clinical Research Centre for Obstetrics and Gynecology, Beijing, China"},{"name":"Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education, Beijing, China"},{"name":"Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Centre for Reproductive Medicine, Peking University Third Hospital, Beijing, China"},{"name":"National Clinical Research Centre for Obstetrics and Gynecology, Beijing, China"},{"name":"Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education, Beijing, China"},{"name":"Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Centre for Reproductive Medicine, Peking University Third Hospital, Beijing, China"},{"name":"National Clinical Research Centre for Obstetrics and Gynecology, Beijing, China"},{"name":"Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education, Beijing, China"},{"name":"Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6622-8134","authenticated-orcid":false,"given":"Rui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben Willem","family":"Mol","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia"},{"name":"Aberdeen Centre for Women's Health Research, School of Medicine, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0305-5579","authenticated-orcid":false,"given":"Rong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Centre for Reproductive Medicine, Peking University Third Hospital, Beijing, China"},{"name":"National Clinical Research Centre for Obstetrics and Gynecology, Beijing, China"},{"name":"Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education, Beijing, China"},{"name":"Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2126-1376","authenticated-orcid":false,"given":"Jie","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Centre for Reproductive Medicine, Peking University Third Hospital, Beijing, China"},{"name":"National Clinical Research Centre for Obstetrics and Gynecology, Beijing, China"},{"name":"Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education, Beijing, China"},{"name":"Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China"},{"name":"Research Units of Comprehensive Diagnosis and Treatment of Oocyte Maturation Arrest, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,28]]},"reference":[{"key":"2022051807111054600_deab243-B1","first-page":"hoz043","article-title":"Growth and other health outcomes of 2-year-old singletons born after IVM versus controlled ovarian stimulation in mothers with polycystic ovary syndrome","volume":"2020","author":"Belva","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2022051807111054600_deab243-B2","first-page":"38","article-title":"In vitro maturation of oocytes in women at risk of ovarian hyperstimulation syndrome\u2014a prospective multicenter cohort study","volume":"13","author":"Braam","year":"2019","journal-title":"Int J Fertil Steril"},{"key":"2022051807111054600_deab243-B3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0015-0282(16)54068-0","article-title":"Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program","volume":"55","author":"Cha","year":"1991","journal-title":"Fertil Steril"},{"key":"2022051807111054600_deab243-B4","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.fertnstert.2013.01.141","article-title":"In vitro maturation of human immature oocytes for fertility preservation","volume":"99","author":"Chian","year":"2013","journal-title":"Fertil Steril"},{"key":"2022051807111054600_deab243-B5","first-page":"15","article-title":"Obstetric outcomes and congenital abnormalities in infants conceived with oocytes matured in vitro","volume":"6","author":"Chian","year":"2014","journal-title":"Facts Views Vis Obgyn"},{"key":"2022051807111054600_deab243-B6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.rbmo.2014.07.019","article-title":"In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome","volume":"29","author":"Das","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"2022051807111054600_deab243-B7","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/humrep\/dew208","article-title":"The definition of IVM is clear-variations need defining","volume":"31","author":"De Vos","year":"2016","journal-title":"Hum Reprod"},{"key":"2022051807111054600_deab243-B8","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/REP-15-0606","article-title":"Oocyte maturation and quality: role of cyclic nucleotides","volume":"152","author":"Gilchrist","year":"2016","journal-title":"Reproduction"},{"key":"2022051807111054600_deab243-B9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fertnstert.2012.04.046","article-title":"In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles","volume":"98","author":"Gremeau","year":"2012","journal-title":"Fertil Steril"},{"key":"2022051807111054600_deab243-B10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.fertnstert.2012.01.114","article-title":"Developmental capacity of in vitro-matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm","volume":"98","author":"Guzman","year":"2012","journal-title":"Fertil Steril"},{"key":"2022051807111054600_deab243-B11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/humrep\/det034","article-title":"A prediction model to select PCOS patients suitable for IVM treatment based on anti-Mullerian hormone and antral follicle count","volume":"28","author":"Guzman","year":"2013","journal-title":"Hum Reprod"},{"key":"2022051807111054600_deab243-B12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13048-018-0445-5","article-title":"Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome","volume":"11","author":"Ho","year":"2018","journal-title":"J Ovarian Res"},{"key":"2022051807111054600_deab243-B13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1055\/s-0030-1265680","article-title":"Ovarian hyperstimulation syndrome prevention strategies: in vitro maturation","volume":"28","author":"Huang","year":"2010","journal-title":"Semin Reprod Med"},{"key":"2022051807111054600_deab243-B14","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.fertnstert.2012.06.055","article-title":"Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome","volume":"98","author":"Junk","year":"2012","journal-title":"Fertil Steril"},{"key":"2022051807111054600_deab243-B151","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/humrep\/deh603","article-title":"In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience","volume":"20","author":"Le Du","year":"2005","journal-title":"Hum Reprod"},{"key":"2022051807111054600_deab243-B15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1210\/me.2014-1173","article-title":"Modifications of human growth differentiation factor 9 to improve the generation of embryos from low competence oocytes","volume":"29","author":"Li","year":"2015","journal-title":"Mol Endocrinol"},{"key":"2022051807111054600_deab243-B16","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/humrep\/det262","article-title":"Prevalence of polycystic ovary syndrome in women in China: a large community-based study","volume":"28","author":"Li","year":"2013","journal-title":"Hum Reprod"},{"key":"2022051807111054600_deab243-B152","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/humrep\/deg335","article-title":"Combination of FSH priming and hCG priming for in-vitro maturation of human oocytes","volume":"18","author":"Lin","year":"2003","journal-title":"Hum Reprod"},{"key":"2022051807111054600_deab243-B17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fendo.2020.00279","article-title":"Human chorionic gonadotropin priming does not improve pregnancy outcomes of PCOS-IVM cycles","volume":"11","author":"Lin","year":"2020","journal-title":"Front Endocrinol"},{"key":"2022051807111054600_deab243-B18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/rep.0.1220587","article-title":"Benefit of FSH priming of women with PCOS to the in vitro maturation procedure and the outcome: a randomized prospective study","volume":"122","author":"Mikkelsen","year":"2001","journal-title":"Reproduction"},{"key":"2022051807111054600_deab243-B19","author":"Monis","year":"2021"},{"key":"2022051807111054600_deab243-B20","first-page":"CD012103","article-title":"Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews","volume":"1","author":"Mourad","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2022051807111054600_deab243-B21","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1148\/radiographics.21.6.g01nv211409","article-title":"Imaging the endometrium: disease and normal variants","volume":"21","author":"Nalaboff","year":"2001","journal-title":"Radiographics"},{"key":"2022051807111054600_deab243-B22","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.fertnstert.2013.06.018","article-title":"A \u201cfreeze-all\u201d embryo strategy after in vitro maturation: a novel approach in women with polycystic ovary syndrome?","volume":"100","author":"Ortega-Hrepich","year":"2013","journal-title":"Fertil Steril"},{"key":"2022051807111054600_deab243-B23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.fertnstert.2020.11.018","article-title":"In vitro maturation: a committee opinion","volume":"115","author":"Practice Committees of the American Society for Reproductive Medicine","year":"2021","journal-title":"Fertil Steril"},{"key":"2022051807111054600_deab243-B24","first-page":"91","article-title":"Assisted reproductive technology in China: compliance and non-compliance","volume":"3","author":"Qiao","year":"2014","journal-title":"Transl Pediatr"},{"key":"2022051807111054600_deab243-B25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.fertnstert.2016.12.026","article-title":"Time-lapse imaging reveals differences in growth dynamics of embryos after in vitro maturation compared with conventional stimulation","volume":"107","author":"Roesner","year":"2017","journal-title":"Fertil Steril"},{"key":"2022051807111054600_deab243-B26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"2022051807111054600_deab243-B27","first-page":"1","article-title":"The management of ovarian hyperstimulation syndrome","volume":"5","author":"Royal college of Obstetricians and Gynaecologists","year":"2016","journal-title":"RCOG Green-Top Guildline"},{"key":"2022051807111054600_deab243-B28","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s10815-019-01551-5","article-title":"Biphasic in vitro maturation (CAPA-IVM) specifically improves the developmental capacity of oocytes from small antral follicles","volume":"36","author":"Sanchez","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"2022051807111054600_deab243-B29","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/humrep\/dex262","article-title":"An improved IVM method for cumulus-oocyte complexes from small follicles in polycystic ovary syndrome patients enhances oocyte competence and embryo yield","volume":"32","author":"Sanchez","year":"2017","journal-title":"Hum Reprod"},{"key":"2022051807111054600_deab243-B30","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/humrep\/dev083","article-title":"Human cumulus-enclosed germinal vesicle oocytes from early antral follicles reveal heterogeneous cellular and molecular features associated with in vitro maturation capacity","volume":"30","author":"Sanchez","year":"2015","journal-title":"Hum Reprod"},{"key":"2022051807111054600_deab243-B31","first-page":"CD006606","article-title":"In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction","volume":"11","author":"Siristatidis","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2022051807111054600_deab243-B153","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/humrep\/deh768","article-title":"Favourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients","volume":"20","author":"S\u00f6derstr\u00f6m-Anttila","year":"2005","journal-title":"Hum Reprod"},{"key":"2022051807111054600_deab243-B32","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1093\/humrep\/dei195","article-title":"Fertilization, cleavage and blastocyst development according to the maturation timing of oocytes in in vitro maturation cycles","volume":"20","author":"Son","year":"2005","journal-title":"Hum Reprod"},{"key":"2022051807111054600_deab243-B33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1472-6483(10)61438-1","article-title":"Effect of gonadotrophin priming on in-vitro maturation of oocytes collected from women at risk of OHSS","volume":"13","author":"Son","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"2022051807111054600_deab243-B34","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1074\/jbc.RA120.013050","article-title":"A variant of human growth differentiation factor-9 that improves oocyte developmental competence","volume":"295","author":"Stocker","year":"2020","journal-title":"J Biol Chem"},{"key":"2022051807111054600_deab243-B35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/GCO.0b013e3282f88e33","article-title":"In-vitro maturation: its role in fertility treatment","volume":"20","author":"Suikkari","year":"2008","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2022051807111054600_deab243-B36","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"2022051807111054600_deab243-B37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/humrep\/13.suppl_3.52","article-title":"Oocyte maturation","volume":"13","author":"Trounson","year":"1998","journal-title":"Hum Reprod"},{"key":"2022051807111054600_deab243-B38","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1093\/humrep\/deaa240","article-title":"In-vitro maturation of oocytes versus conventional IVF in women with infertility and a high antral follicle count: a randomized non-inferiority controlled trial","volume":"35","author":"Vuong","year":"2020","journal-title":"Hum Reprod"},{"key":"2022051807111054600_deab243-B39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/humrep\/deu248","article-title":"In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes","volume":"30","author":"Walls","year":"2015","journal-title":"Hum Reprod"},{"key":"2022051807111054600_deab243-B40","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/humrep\/dev125","article-title":"In vitro maturation is associated with increased early embryo arrest without impairing morphokinetic development of useable embryos progressing to blastocysts","volume":"30","author":"Walls","year":"2015","journal-title":"Hum Reprod"},{"key":"2022051807111054600_deab243-B41","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1093\/humrep\/13.11.3132","article-title":"Pretreatment with follicle stimulating hormone promotes the numbers of human oocytes reaching metaphase II by in-vitro maturation","volume":"13","author":"Wynn","year":"1998","journal-title":"Hum Reprod"},{"key":"2022051807111054600_deab243-B42","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/humrep\/des099","article-title":"Effects of combined epidermal growth factor, brain-derived neurotrophic factor and insulin-like growth factor-1 on human oocyte maturation and early fertilized and cloned embryo development","volume":"27","author":"Yu","year":"2012","journal-title":"Hum Reprod"},{"key":"2022051807111054600_deab243-B43","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","article-title":"The international glossary on infertility and fertility care, 2017","volume":"108","author":"Zegers-Hochschild","year":"2017","journal-title":"Fertil Steril"},{"key":"2022051807111054600_deab243-B44","doi-asserted-by":"crossref","first-page":"e035334","DOI":"10.1136\/bmjopen-2019-035334","article-title":"Live birth after in vitro maturation versus standard in vitro fertilisation for women with polycystic ovary syndrome: protocol for a non-inferiority randomised clinical trial","volume":"10","author":"Zheng","year":"2020","journal-title":"BMJ Open"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/2\/242\/43745818\/deab243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/2\/242\/43745818\/deab243.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T07:12:25Z","timestamp":1652857945000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/37\/2\/242\/6445210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,28]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,11,28]]},"published-print":{"date-parts":[[2022,1,28]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deab243","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,11,28]]}}}